Alta Semper Capital, a London-based private equity firm focused on healthcare and consumer investments in high-growth markets, announced it has secured $57.5 million in commitments for Alta Semper Growth Fund II from a consortium of investors led by the European Investment Bank (EIB) Group and the International Finance Corporation (IFC).
The firm said the EIB Group—comprised of the European Investment Bank and the European Investment Fund—has committed $37.5 million, while the IFC has committed $20.0 million. The partnership was marked with a signing ceremony held at a government ministry in Cairo, according to the firm.
Alta Semper said Growth Fund II is targeting a total fund size of $150 million and will focus on scaling market-leading healthcare and consumer businesses that expand access to affordable, high-quality products and services across Africa and other select growth markets. The fund’s focus areas include primary care, preventative medicine, diagnostics, medical devices, digital health, consumer wellness platforms, and disruptive technology.
The firm said the EIB’s investment aligns with the EU-Africa Global Gateway Investment Package and the EU Global Health Strategy, with an emphasis on resilient health systems and regional manufacturing capacity. Alta Semper added that the IFC’s commitment builds on an existing relationship, noting the IFC previously served as an anchor investor in Alta Semper Fund I.
Alta Semper also said Egypt’s Micro, Small and Medium Enterprise Development Agency (MSMEDA) attended the signing ceremony to represent its commitment to the fund, and that MSMEDA’s involvement is expected to conclude in the coming months. The firm said MSMEDA’s participation is intended to support the growth of medium-sized enterprises—particularly in healthcare and consumer goods—while supporting job creation within Egypt.
The new commitments are expected to provide long-term capital to businesses across the Middle East and North Africa (MENA) and Sub-Saharan Africa (SSA), with Alta Semper highlighting anticipated contributions including strengthening local supply chains, promoting high ESG standards, and supporting jobs across the portfolio.
Alta Semper has already begun deploying capital from Growth Fund II, citing investments including MYDAWA, a digital health platform in East Africa, and Allmed Group, a medical device company focused on blood purification and renal care solutions.
KEY QUOTE:
“Securing commitments from the EIB Group and the IFC is a strong endorsement of Alta Semper’s strategy and track record. These partnerships significantly enhance our ability to scale high-quality healthcare and consumer businesses, accelerate the adoption of technology, and deepen our impact on the ground. Our ambition is to help build resilient, equitable, and future-proof health ecosystems that deliver meaningful outcomes for communities while generating attractive returns for our investors.”
Afsane Jetha, Managing Partner and CEO, Alta Semper
